Last week, Dublin biotechnology company Nuritas announced a $45 million funding round to help accelerate its global expansion, bring its total funding to date to a hefty $75 million. The Series B round was led by Chicago-based Cleveland Avenue, the food investor fund led by Don Thompson, the former president and CEO of McDonald’s Corporation. The company said other backers included Grosvenor’s Wheatsheaf Group, the European Circular Bioeconomy Fund (ECBF), Vertex Holdings, Nutresa Ventures/Veronorte and CJ. However, it has now emerged that a number of the company’s early investors – including three members of U2 and also the state agency…

Want to continue reading?

Introductory offer: Sign up today and pay €200 for an annual membership, a saving of €50.

Subscribe

Cancel at any time.

Are you already a member? .